Filter
Exclude
Time range
-
Minimum likes
📝Editorial perspective: The DCD juggernaut continues! As DCD moves from innovation to infrastructure, success must be measured beyond outcomes. Ethical stewardship, transparency, cost-effectiveness & preservation of public trust are critical to its future. 🧵👇
1
1
3
251
🚨New Science Alert! 🫀DCD heart transplantation has expanded rapidly nationwide to more centers & higher-risk recipients. Yet graft failure, mortality & other early outcomes remained stable. This UNOS analysis supports the robustness & scalability of DCD. 🧵👇
2
5
11
1,157
🌍How do countries decide who gets a donor heart first? This research article analyzes heart allocation policies globally. Across 29 countries, 93% of allocation systems use urgency tiers. But how urgency, MCS priority, & exceptions are defined varies widely. 🧵👇
2
4
13
720
⏰Final Call Submissions for JCF's Focus Issue: The New Frontier of Heart Function in Women close soon. If your research advances women's cardiovascular health, now's the time to submit. 📅 Submissions close tomorrow, 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth
7
12
3,316
🫀 Heart transplantation is entering a new era! This State-of-the-Art review explores advances reshaping the field: individualized LVAD vs transplant decisions, DCD & HCV+ donors, and new organ preservation strategies expanding the donor pool. 🔗 bit.ly/45xVQXm 🧵👇
2
13
27
2,086
What's next in heart transplantation? 🫀 Find out in the September Focus Issue on Innovations in Heart Transplantation. Explore research and perspectives on new developments advancing heart transplantation care. 🔗 onlinejcf.com/current #HeartTransplantation #Cardiology
10
14
3,430
📝 Editorial perspective Discordance between PAWP and LVEDP shouldn't simply lead us to discount LVEDP. Instead, the pressure difference may offer important clues to underlying pathology affecting left atrial function. 🫀 🔗 bit.ly/4ibdM1p @MicheleEmdin
5
6
290
🚨New science alert! PAWP or LVEDP ... which better predicts outcomes? Using simultaneous invasive hemodynamics at rest & during exercise, this study found that PAWP better reflected hemodynamic abnormalities & predicted adverse HF outcomes. 🫀 🔗 bit.ly/4x64Z5K
1
9
19
1,865
⏳ The deadline is approaching. JCF is still accepting submissions for the Focus Issue: The New Frontier of Heart Function in Women. If your research advances women's cardiovascular health, we encourage you to submit by 9/15/26. bit.ly/4xQkPSR
3
3
614
🧬Precision medicine begins with a diagnosis. In the largest real-world study to date, only 1.05% of patients with cardiomyopathy underwent genetic testing and just 7% received genetic counseling. Implementation — not evidence — remains the challenge. 🔗 bit.ly/4qpMbvF
2
7
506
🫀🧬 Is suPAR more than a biomarker? In SOLOIST-WHF, higher baseline suPAR predicted worse HF outcomes, but sotagliflozin reduced events regardless of suPAR and did not lower suPAR levels — pointing to residual inflammatory risk. 🔗 bit.ly/4qjyrT0
1
5
10
950
📝 Editorial perspective DCD heart transplantation shouldn't be limited to high-volume centers. With standardized procurement, appropriate infrastructure & shared expertise, broader adoption could reduce geographic disparities & improve access. 🫀 🔗 bit.ly/4658cGz
1
2
188
🫀Does transplant center volume influence DCD heart transplant outcomes? This UNOS analysis found similar perioperative outcomes and short-term survival at high & low-volume centers, supporting the growing robustness & reproducibility of DCD transplantation. 🧵👇
3
1
6
797
🫀Is predicted heart mass still the best way to size-match donor hearts? This Perspective questions PHM in the modern era, highlighting its limitations in obesity & calling for next-generation metrics that better reflect body composition & cardiac size. bit.ly/45xRZtm
7
12
1,042
📝 Editorial perspective The question isn't whether OOS heart tx should expand or disappear. It's how to give it structured legitimacy. Standardized criteria, transparency, and better data will be key to ensuring equitable organ allocation. 🫀 🔗 bit.ly/462hfbo
1
5
246
🫀Out-of-sequence heart transplantation remains uncommon. But it's growing. This study found OOS allocation increased from 1.4% to 3.1%, was concentrated in a small number of OPOs & centers, & achieved similar 1-year survival to standard allocation. 🔗 bit.ly/4qhMFDS
1
7
17
1,191
Out now! The August issue of JCF is live. Catch up on the latest research and insights in heart failure. See what’s inside 👉 onlinejcf.com/current #HeartFailure #Cardiology #HeartFailureResearch
2
9
687
Impact is built together. 🫀🌎 It’s the research shared. The mentorship given. The conversations started. The connections made across the global heart failure community. At JCF, our Impact Factor reflects something much bigger: what we can accomplish together.
3
8
814